HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eriko Yoshida Selected Research

paramylon

11/2013Antitumor activity of the β-glucan paramylon from Euglena against preneoplastic colonic aberrant crypt foci in mice.
6/2010Oral administration of paramylon, a beta-1,3-D-glucan isolated from Euglena gracilis Z inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice.
7/2009Hepatoprotective effects of paramylon, a beta-1, 3-D-glucan isolated from Euglena gracilis Z, on acute liver injury induced by carbon tetrachloride in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eriko Yoshida Research Topics

Disease

2Hypertrophy
01/2022 - 06/2010
2Body Weight (Weight, Body)
11/2013 - 07/2009
1COVID-19
01/2022
1Hemorrhage
01/2022
1Vasculitis (Vasculitides)
01/2022
1Glomerulonephritis
01/2022
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022
1Portal Hypertension
01/2014
1Colonic Neoplasms (Colon Cancer)
11/2013
1Aberrant Crypt Foci
11/2013
1Atopic Dermatitis (Atopic Eczema)
06/2010
1Dermatitis
06/2010
1Weight Loss (Weight Reduction)
06/2010
1Necrosis
07/2009

Drug/Important Bio-Agent (IBA)

3paramylonIBA
11/2013 - 07/2009
1BNT162 VaccineIBA
01/2022
1Fish ProteinsIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
11,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
11/2013
1Dimenhydrinate (DMH)FDA LinkGeneric
11/2013
1GlucansIBA
11/2013
1Immunoglobulin E (IgE)IBA
06/2010
1Prednisolone (Predate)FDA LinkGeneric
06/2010
1polysaccharide-KIBA
06/2010
1EnzymesIBA
07/2009
1Coloring Agents (Dyes)IBA
07/2009

Therapy/Procedure

1Therapeutics
01/2022
1Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2014
1Oral Administration
06/2010